Pharma-Bio Serv Past Earnings Performance

Past criteria checks 0/6

Pharma-Bio Serv's earnings have been declining at an average annual rate of -27.4%, while the Life Sciences industry saw earnings growing at 13.9% annually. Revenues have been declining at an average rate of 7.2% per year.

Key information

-27.4%

Earnings growth rate

-27.4%

EPS growth rate

Life Sciences Industry Growth21.5%
Revenue growth rate-7.2%
Return on equity-6.1%
Net Margin-7.8%
Last Earnings Update31 Jul 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Pharma-Bio Serv makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:PBSV Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Jul 2411-140
30 Apr 2413040
31 Jan 2415140
31 Oct 2317140
31 Jul 2318240
30 Apr 2318140
31 Jan 2319140
31 Oct 2219140
31 Jul 2220-490
30 Apr 2221-290
31 Jan 2221-290
31 Oct 2120-290
31 Jul 2120340
30 Apr 2121140
31 Jan 2121240
31 Oct 2022240
31 Jul 2021240
30 Apr 2020250
31 Jan 2020240
31 Oct 1920240
31 Jul 1920250
30 Apr 1920250
31 Jan 1919250
31 Oct 1818-150
31 Jul 1813-240
30 Apr 1813-340
31 Jan 1813-340
31 Oct 1713-150
31 Jul 1717-150
30 Apr 1717-160
31 Jan 1719-160
31 Oct 1620060
31 Jul 1621160
30 Apr 1622160
31 Jan 1622260
31 Oct 1523260
31 Jul 1525260
30 Apr 1525260
31 Jan 1526260
31 Oct 1428260
31 Jul 1429360
30 Apr 1431360
31 Jan 1432560

Quality Earnings: PBSV is currently unprofitable.

Growing Profit Margin: PBSV is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PBSV is unprofitable, and losses have increased over the past 5 years at a rate of 27.4% per year.

Accelerating Growth: Unable to compare PBSV's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PBSV is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-10.7%).


Return on Equity

High ROE: PBSV has a negative Return on Equity (-6.14%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies